| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0006 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.16 | 0.006 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.094 | 0.007 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |